{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T09:43:25Z","timestamp":1696239805247},"reference-count":16,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:00:00Z","timestamp":1428537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Cancer"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>To study the relationship between loss of heterozygosity (<jats:styled-content style=\"fixed-case\">LOH<\/jats:styled-content>) at the human leukocyte antigen (<jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>) locus and the pathogenicity and clinicopathological features of thymic epithelial tumors (<jats:styled-content style=\"fixed-case\">TET<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Tumor and adjacent normal tissues were isolated from 36 <jats:styled-content style=\"fixed-case\">TET<\/jats:styled-content> patients. Five microsatellite loci (<jats:styled-content style=\"fixed-case\">D6S1666<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">D6S265<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">D6S273<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">DS6276<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">D6S291<\/jats:styled-content>) within the <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content> locus were amplified by polymerase chain reaction. <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> sequencing was used to measure the frequency of microsatellite <jats:styled-content style=\"fixed-case\">LOH<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">LOH<\/jats:styled-content> was identified in at least one locus in 83.6% of <jats:styled-content style=\"fixed-case\">TET<\/jats:styled-content> patients. <jats:styled-content style=\"fixed-case\">LOH<\/jats:styled-content> frequency at <jats:styled-content style=\"fixed-case\">D6S1666<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">D6S265<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">D6S273<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">D6S276<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">D6S291<\/jats:styled-content> was 44.4%, 16.7%, 30.5%, 38.9%, and 36.1% respectively. There was no significant association between <jats:styled-content style=\"fixed-case\">LOH<\/jats:styled-content> frequency in <jats:styled-content style=\"fixed-case\">TET<\/jats:styled-content> with tumor severity, or in the presence or absence of myasthenia gravis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">D6S1666<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">D6S265<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">D6S273<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">DS6S276<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">D6S29<\/jats:styled-content> are sensitive loci for studying microsatellite <jats:styled-content style=\"fixed-case\">LOH<\/jats:styled-content> in <jats:styled-content style=\"fixed-case\">TET<\/jats:styled-content>. <jats:styled-content style=\"fixed-case\">LOH<\/jats:styled-content> within the <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content> complex is implicated in the occurrence and development of <jats:styled-content style=\"fixed-case\">TET<\/jats:styled-content>, with the <jats:styled-content style=\"fixed-case\">HLA\u2010DQA1<\/jats:styled-content> gene likely involved. However, an understanding of the relationship between <jats:styled-content style=\"fixed-case\">LOH<\/jats:styled-content> and the clinicopathological features of <jats:styled-content style=\"fixed-case\">TET<\/jats:styled-content> requires a larger sample size than that of the present study.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1759-7714.12252","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T08:02:59Z","timestamp":1428566579000},"page":"749-753","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Loss of heterozygosity at the human leukocyte antigen locus in thymic epithelial tumors"],"prefix":"10.1111","volume":"6","author":[{"given":"Yuan","family":"Chen","sequence":"first","affiliation":[{"name":"Deparment of Cardiothoracic Surgery Tianjin Medical University General Hospital  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojin","family":"Wang","sequence":"additional","affiliation":[{"name":"Deparment of Hematology and Oncology Tianjin Medical University General Hospital  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Deparment of Cardiothoracic Surgery Tianjin Medical University General Hospital  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimei","family":"Liu","sequence":"additional","affiliation":[{"name":"Deparment of Cardiothoracic Surgery Tianjin Medical University General Hospital  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Yao","sequence":"additional","affiliation":[{"name":"Deparment of Cardiothoracic Surgery Tianjin Medical University General Hospital  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Wang","sequence":"additional","affiliation":[{"name":"Deparment of Cardiothoracic Surgery Tianjin Medical University General Hospital  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanguo","family":"Wang","sequence":"additional","affiliation":[{"name":"Deparment of Cardiothoracic Surgery Tianjin Medical University General Hospital  Tianjin China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.01.014"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-010-0494-4"},{"key":"e_1_2_8_4_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00262-002-0332-0","article-title":"Analysis of HLA expression in human tumor tissues","volume":"52","author":"Cabrera T","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.3342\/ceo.2014.7.1.53"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63031-3"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64426-4"},{"key":"e_1_2_8_8_1","first-page":"3708","article-title":"Correlating genetic aberrations with World Health Organization\u2010defined histology and stage across the spectrum of thymomas","volume":"63","author":"Inoue M","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_8_9_1","first-page":"2741","article-title":"Loss of heterozygosity at 6p21 and HLA class I expression in esophageal squamous cell carcinomas in China","volume":"12","author":"Zhao X","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"key":"e_1_2_8_10_1","first-page":"2152","article-title":"D6S439 microsatellite identifies a new susceptibility region for primary Sj\u00f6gren's syndrome","volume":"30","author":"Anaya JM","year":"2003","journal-title":"J Rheumatol"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000154"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63617-6"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1191\/1352458502ms804oa"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012080771"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2010.06.021"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-002-0296-0"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64536-1"}],"container-title":["Thoracic Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1759-7714.12252","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1759-7714.12252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T11:23:17Z","timestamp":1696159397000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1759-7714.12252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,9]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1111\/1759-7714.12252"],"URL":"https:\/\/doi.org\/10.1111\/1759-7714.12252","archive":["Portico"],"relation":{},"ISSN":["1759-7706","1759-7714"],"issn-type":[{"value":"1759-7706","type":"print"},{"value":"1759-7714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,9]]},"assertion":[{"value":"2014-11-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-01-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-04-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}